1. |
胡亚, 廖泉, 曹少博, 等.原发性甲状旁腺功能亢进术后低钙血症相关因素分析.中国实用外科杂志, 2016, 36(1):119-121.
|
2. |
Dolan JP, Norton JA. Surgery for persistent and recurrent primary hyperparathyroidism//Doherty GM, Skogseid B. Surgical endocrinology. Philadelphia, PA:Lippincott Williams Wilkins, 2001:173-187.
|
3. |
Mizrachi A, Gilat H, Bachar G, et al. Elevated parathyroid hormone levels after parathyroidectomy for primary hyperparathyroidism. Head Neck, 2009, 31(11):1456-1460.
|
4. |
Nordenström E, Westerdahl J, Bergenfelz A. Long-term follow-up of patients with elevated PTH levels following successful exploration for primary hyperparathyroidism. World J Surg, 2004, 28(6):570-575.
|
5. |
Carsello CB, Yen TW, Wang TS. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy:does it matter?. Surgery, 2012, 152(4):575-583.
|
6. |
Solorzano CC, Mendez W, Lew JI, et al. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism. Arch Surg, 2008, 143(7):659-663.
|
7. |
黄朔, 李明振, 杜井峰, 等.甲状旁腺术后甲状旁腺激素升高伴血钙正常的病例分析.中国普通外科杂志, 2010, 19(11):1183-1186.
|
8. |
Westerdahl J, Valdemarsson S, Lindblom P, et al. Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma:sign of bone remineralization and decreased calcium absorption. World J Surg, 2000, 24(11):1323-1329.
|
9. |
Mittendorf EA, McHenry CR. Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg, 2002, 128(3):275-279.
|
10. |
Yamashita H, Noguchi S, Moriyama T, et al. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism:importance of decreased renal parathyroid hormone sensitivity. Surgery, 2005, 137(4):419-425.
|
11. |
Wang TS, Ostrower ST, Heller KS. Persistently elevated parathyroid hormone levels after parathyroid surgery. Surgery, 2005, 138(6):1130-1136.
|
12. |
Bergenfelz A, Valdemarsson S, Tibblin S. Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma:evidence of detrimental effects of severe parathyroid disease. Surgery, 1996, 119(6):624-633.
|
13. |
Beyer TD, Solorzano CC, Prinz RA, et al. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery, 2007, 141(6):777-783.
|
14. |
Ning L, Sippel R, Schaefer S, et al. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism?. Ann Surg, 2009, 249(3):469-472.
|
15. |
Yen TW, Wilson SD, Krzywda EA, et al. The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery, 2006, 140(4):665-674.
|
16. |
Denizot A, Pucini M, Chagnaud C, et al. Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg, 2001, 182(1):15-19.
|
17. |
Dhillon KS, Cohan P, Darwin C, et al. Elevated serum parathyroid hormone concentration in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism and its relationship to vitamin D profile. Metabolism, 2004, 53(9):1101-1106.
|
18. |
Goldfarb M, Gondek S, Irvin GL 3rd, et al. Normocalcemic parathormone elevation after successful parathyroidectomy:long-term analysis of parathormone variations over 10 years. Surgery, 2011, 150(6):1076-1084.
|
19. |
Mandal AK, Udelsman R. Secondary hyperparathyroidism is an expected consequence of parathyroidectomy for primary hyperparathyroidism:a prospective study. Surgery, 1998, 124(6):1021-1027.
|
20. |
Lundgren E, Rastad J, Ridefelt P, et al. Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. Surgery, 1992, 112(6):1123-1129.
|
21. |
Mulder H, Hackeng WH, Koster J, et al. Normocalcemia with persistent increase of parathyroid hormone:a prospective study. Calcif Tissue Int, 1992, 51(1):27-29.
|
22. |
Lang BH, Wong IY, Wong KP, et al. Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism:risk factors, trend, and outcome. Ann Surg Oncol, 2012, 19(2):584-590.
|
23. |
Lewin IG, Papapoulos SE, Hendy GN, et al. Reversible resistance to the renal action of parathyroid hormone in human vitamin D deficiency. Clin Sci (Lond), 1982, 62(4):381-387.
|
24. |
Nordenström E, Westerdahl J, Isaksson A, et al. Patients with elevated serum parathyroid hormone levels after parathyroidectomy:showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg, 2003, 27(2):212-215.
|
25. |
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly:consequences for bone loss and fractures and therapeutic implications. Endocr Rev, 2001, 22(4):477-501.
|
26. |
Schneider DF, Mazeh H, Chen H, et al. Predictors of recurrence in primary hyperparathyroidism:an analysis of 1386 cases. Ann Surg, 2014, 259(3):563-568.
|
27. |
Stuart HC, Harvey A, Pasieka JL. Normocalcemic hyperparathyroidism:preoperatively a disease, postoperatively cured?. Am J Surg, 2014, 207(5):673-681.
|
28. |
Hedbäck G, Odén A, Tisell LE. The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg, 1991, 15(3):399-407.
|
29. |
Söreide JA, van Heerden JA, Grant CS, et al. Survival after surgical treatment for primary hyperparathyroidism. Surgery, 1997, 122(6):1117-1123.
|
30. |
Stefenelli T, Abela C, Frank H, et al. Cardiac abnormalities in patients with primary hyperparathyroidism:implications for follow-up. J Clin Endocrinol Metab, 1997, 82(1):106-112.
|
31. |
Iwamoto N, Sato N, Nishida M, et al. Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients. Clin Exp Nephrol, 2015, [Epub ahead of print].
|
32. |
McMahon DJ, Carrelli A, Palmeri N, et al. Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism:a meta-analysis. J Clin Endocrinol Metab, 2015, 100(12):4399-4407.
|
33. |
Symons C, Fortune F, Greenbaum RA, et al. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism-an association. Br Heart J, 1985, 54(5):539-542.
|
34. |
Vestergaard H, ØStergaard Kristensen L. Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma:evidence of increased morbidity from cardiovascular disease. World J Surg, 2002, 26(6):657-660.
|
35. |
Tordjman KM, Yaron M, Izkhakov E, et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol, 2010, 162(5):925-933.
|
36. |
Chen G, Xue Y, Zhang Q, et al. Is normocalcemic primary hyperparathyroidism harmful or harmless?. J Clin Endocrinol Metab, 2015, 100(6):2420-2424.
|
37. |
Carty SE, Roberts MM, Virji MA, et al. Elevated serum parathormone level after 'concise parathyroidectomy' for primary sporadic hyperparathyroidism. Surgery, 2002, 132(6):1086-1093.
|
38. |
Biskobing DM. Significance of elevated parathyroid hormone after parathyroidectomy. Endocr Pract, 2010, 16(1):112-117.
|
39. |
Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine:what clinicians need to know. J Clin Endocrinol Metab, 2011, 96(1):53-58.
|